For an investor, nothing can be more exciting than getting in on the ground floor of a company as it first goes public. Investing in an IPO can also be a very lucrative endeavor, as shareholders of these two 2014 recent IPOs can attest.

TubeMogul

TubeMogul Inc TUBE 1.4%, a digital branding service provider, went public back in July 2014. After IPO shares priced at $7 (below the original expected rage of $11-$13), the stock surged more than 50 percent on its first day of trading.

Peaking as high as $23.83 in December, the stock is now sitting around $20.20. Investors that weren’t lucky enough to get in on the TubeMogul IPO, but acted quickly on its first day of trading, have still enjoyed a 75 percent gain from the stock’s opening market price.

Related Link: The Top IPO Of 2014

Immune Design

Immune Design Corp IMDZ 3.55% also went public last July. The Seattle-based company is focused on targeting cancerous tumors and treating them by utilizing the immune system’s natural ability to create tumor-specific cytotoxic T cells.

Immune Design Corp’s drugs are currently in phase 1 clinical trials. After pricing its IPO at $12, the low end of the projected range, the first day of trading was relatively quiet for Immune Design, and the stock closed the day at $12.05.

However, the stock took off in the following months and never looked back, reaching an all-time high of just above $40.00 in December. The recent price of $31.70 represents about a 163 percent gain for IPO investors and early open-market buyers.

Upcoming IPOs

Shares of…

Read the rest of this article (and all my other articles) for free on Benzinga by clicking here

Want to learn more about the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common Sense. I don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and tradingcommonsense.com is always available on your local internet!